FHFiliz Hazan

Filiz Hazan

*This is an algorithmically generated author record based on publicly available information.

Filiz Hazan has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Expanding mutational landscape and clinical phenotype of the CASK-related neurological disorders

    by Mert Pekerbas, Kutay Bulut, Ayca Yigit, Buse Sahin, Baris Salman, Burcu Akman, Emre Ozzeybek, Huseyin Bahadir Senol, Berk Ozyilmaz, Seda Gunes, et al.

    CASK-related disorders comprise two main phenotypes: severe microcephaly with pontocerebellar hypoplasia (MICPCH), typically caused by truncating variants, and milder X-linked intellectual disability (XLID), usually associated with missense variants. We aimed to characterize this molecular spectrum within an underrepresented national cohort. We evaluated 18 affected individuals from 16 unrelated families with CASK variants identified through exome or genome sequencing. Clinical, neurodevelopmental and neuroimaging findings were systematically reviewed. Selected missense variants were evaluated by in silico prediction tools and structural modeling. We identified 16 distinct CASK variants, 11 of which are novel, including frameshift, stop-gain, splice-site, and missense variants, as well as one large deletion. Consistent with known genotype-phenotype correlations, null alleles resulted in the severe MICPCH phenotype, while presumed hypomorphic alleles were associated with XLID. However, unlike previous reports, our MICPCH patients exhibited a higher frequency of dysmorphic facial features (86%), skeletal anomalies (57%) and sensorineural hearing loss (43%). Furthermore, contrary to the literature suggesting a milder epilepsy in females due to X-inactivation, 63% of our female patients with MICPCH presented with recurrent seizures. This cohort broadens both the molecular and phenotypic spectrum of CASK-related disorders. Findings reinforce that truncating variants predominantly cause MICPCH, while missense variants can lead to various outcomes depending on domain-level structural impact. We demonstrate that the CASK phenotypic spectrum is broader than previously recognized, frequently involving distinctive facial dysmorphism, skeletal defects and hearing impairment, suggesting that CASK plays a critical role not only in synaptic function but also in wider developmental processes.

  • Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants

    by Karalar Pekuz, Ozge Kamer, Pelin Teke Kisa, Sevil Yildiz, Mehmet Kocabey, Tanyel Zubarioglu, Zumrut Arslan Gulten, Emine Sedef Sezen, Esra Er, Serdar Pekuz, et al.

  • Clinical and molecular characterization of 5α-reductase deficiency type 2: First report of a family with homozygous deletion in exon 1 of SRD5A2

    by Özge Köprülü, Filiz Hazan, Esra Bal Yüksel, İbrahim Mert Erbaş, Özlem Nalbantoğlu, Hüseyin Anıl Korkmaz, Tarık Kırkgöz, Behzat Özkan

  • Retrovesical Hybrid Benign Peripheral Nerve Sheath Tumor with a Heterozygous Germline NF2 Deletion in a 12-Year-Old Boy: A Case Report

    by Mehmet Can, Ayşe Gül Tavukçu Tantay, Tolga Yüksel, Özkan Okur, Filiz Hazan, Durdugül Ayyıldız Emecen

    Hybrid benign peripheral nerve sheath tumors (BPNSTs) are a relatively recently recognized group of nerve sheath neoplasms composed of variable proportions of schwannomatous, neurofibromatous, and/...

  • Genetic evaluation of a group of patients with transient congenital hypothyroidism by targeted exome sequencing

    by Özge Köprülü, Sezer Acar, Ceren Yılmaz Uzman, İbrahim Mert Erbaş, Özlem Nalbantoğlu, Filiz Hazan, Semra Gürsoy, Hüseyin Anıl Korkmaz, Behzat Özkan

    Objectives: Transient congenital hypothyroidism (TCH) is characterized by congenital hypothyroidism (CH) which spontaneously resolves in the first years of life. While most cases are sporadic, several studies from worldwide showed variants in DUOX2 , DUOXA2, TSHR genes in the etiology of TCH. The aim of our study is to evaluate the genetic etiology of TCH. Methods: A total of 54 patients from 50 families with TCH were included the study. The age at diagnosis, age at time of drug discontinuation, gender, consanguinity, the presence of additional examination findings, venous fT4 and TSH levels at the time of diagnosis, at time of drug discontinuation and at the last visit, the follow-up data and genetic characteristics were obtained from records. Results: A total of 54 patients from 50 families [59.3 % male (n=32) and 40.7 % female (n=22)] with TCH were included in the study. Pathogenic variants were detected in 15 out of 54 patients. 10 different DUOX2 variants (c.1060C>T, c.1547G>A, c.2597T>G, c.3314T>C, c.3382C>A, c.3509A>C, c.3790A>G, c.4445C>T, c.28del, c.533G>T) were identified in 11 patients (2 homozygous, 3 compound heterozygous, and 6 heterozygous). Conclusions: Our findings suggest that DUOX2 variants are the main genetic cause of TCH. We reported novel variants in the DUOX2 and TSHR genes that expand their mutational spectrum. These findings support the need for incorporating molecular analysis into the diagnostic evaluation of TCH, not only to improve our knowledge of its genetic underly, but also to provide valuable insights for long-term follow-up, family counseling, and personalized management strategies.


  • Open Access

    TRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease

    by Aslı Kantar, Duygu Güllü, Yakup Yaman, Betül Pehlivan Zorlu, Derya Özmen, Fatma Devrim, Şükran Keskin Gözmen, Filiz Hazan, Aycan Ünalp, Nida Dinçel

    Background: TRACK syndrome, first described by Canpolat et al., is a rare disorder caused by splice-site mutations in TSEN2, characterized by craniofacial malformations, central nervous system (CNS) anomalies, progressive kidney disease. Case Presentation: We present a 2.5-year-old boy, third child of consanguineous parents, admitted with fever and cough, diagnosed with atypical hemolytic uremic syndrome (aHUS). Whole exome sequencing revealed a homozygous intronic TSEN2 variant (c.1100-5T>A), consistent with TRACK syndrome. Two deceased siblings had similar dysmorphic features and early-onset renal failure. The proband exhibited microcephaly, craniofacial dysmorphism, left atrial dilation, and laboratory findings consistent with thrombotic microangiopathy (TMA). Despite pathogenic TSEN2 variant, he’d normal intellectual and motor development. He’s currently 6 years old, undergoing peritoneal dialysis, receiving biweekly eculizumab, and antiepileptic therapy. Conclusion: This report highlights a rare cause of aHUS and end-stage kidney disease (ESKD) due to a TSEN2 splice-site mutation, further expanding the phenotypic spectrum of TRACK syndrome.

  • Open Access

    Expanding the clinical spectrum of Cernunnos/XLF deficiency: a literature review of a rare cause of severe combined immunodeficiency including a novel case

    by Gizem Kabadayı, Özge Atay, Damla Baysal Bakır, Halime Yağmur, Esma Tuğba Kaşıkçı Mermer, Sultan Okur Acar, Şerife Öztürk Yılmaz, Filiz Hazan, Salih Gözmen, Nevin Uzuner

    Severe combined immunodeficiency (SCID) is a congenital immunodeficiency characterized by significant numerical or functional defects in T lymphocytes and is often accompanied by B lymphocyte dysfunction. It presents early in life with severe, recurrent opportunistic infections. Early diagnosis and hematopoietic stem cell transplantation (HSCT) are vital for patient survival. Cernunnos/XLF deficiency is an autosomal recessive form of SCID caused by mutations in the NHEJ1 gene, which plays a critical role in repairing DNA double-strand breaks. First described in 2006, this condition remains exceedingly rare, with only about 55 cases reported to date. This study aimed to describe a novel infant with Cernunnos/XLF deficiency and to review previously reported patients carrying the same variant, thereby expanding the clinical spectrum of this rare disease. With written informed consent, we retrospectively evaluated a pediatric patient with Cernunnos/XLF deficiency followed at our clinic. Demographic, clinical, laboratory, and radiological findings were reviewed. The diagnosis was based on clinical and immunological features and confirmed via clinical exome sequencing. A literature review was conducted to compare the genotype–phenotype correlations of previously reported patients carrying the same NHEJ1 variant. We report an infant who was hospitalized at 6.5 months of age with a preliminary diagnosis of meningitis and was subsequently diagnosed with Cernunnos/XLF deficiency. The patient exhibited microcephaly, growth retardation, recurrent infections, prolonged SARS-CoV-2 PCR positivity, and localized BCGitis following live Bacillus Calmette–Guérin (BCG) vaccination. Immunological evaluation revealed T- and B-cell lymphopenia and hypogammaglobulinemia. Genetic testing confirmed a homozygous nonsense mutation in NHEJ1. HSCT from a matched sibling donor was performed. This study describes a rare case of Cernunnos/XLF deficiency diagnosed in early infancy, underscoring the value of early recognition and the critical role of genetic testing and HSCT. It also expands the clinical spectrum of the disease and provides a comparative perspective with previously reported patients carrying the same mutation. In infants presenting with unexplained infections or complications related to live vaccines, inborn errors of immunity should be considered. Our findings emphasize the importance of timely diagnosis and comprehensive, multidisciplinary follow-up, particularly in patients with additional complications.


  • The Clinical and Molecular Spectrum of Patients With X-Linked Intellectual Disability and Novel Variations in Different Genes

    by Semra Gürsoy, Ceren Yılmaz Uzman, Kadri Murat Erdoğan, Pakize Karaoğlu, Tuba Sözen Türk, Ünsal Yılmaz, Aycan Ünalp, Filiz Hazan


  • A rare case of skeletal dysplasia: biallelic variant in ACAN gene

    by Gülçin Arslan, Filiz Hazan, Gülin Tabanlı, Tarık Kırkgöz, Behzat Özkan

    Objectives: Spondylo-epimetaphyseal dysplasia-aggregan (SEMD-ACAN) is a rare form of osteo-chondrodysplasia that includes vertebral, epiphyseal and metaphyseal dysplasia. It occurs as a result of loss-of-function mutations in the ACAN gene, which encodes aggregan protein, which is the basic component of the extracellular matrix in cartilage. It results in disproportionately short stature and skeletal abnormalities. Here, we aimed to present the fourth SEMD-ACAN report in the literature. Case presentation: A 9-year-old girl was admitted to our clinic with growth retardation. She was born from a first-degree cousin marriage with severe short stature (41 cm; −3.54 SDS). Her mother also had severe short stature. Her height was 110 cm (−4.6 SDS); she had midface hypoplasia, low-set ears, short neck, short limbs, and central obesity. Biochemical and hormonal tests were normal. Skeletal survey showed moderate platyspondylia, thoracolumbar scoliosis, lumbar lordosis, bilateral femoro-acetabular narrowing, and advanced bone age (10 years). The patient’s brother was 100 cm (−3.97 SDS). He had similar but milder clinical findings. Biallelic ACAN variation (c.512C>T; p. Ala171Val) was detected in two siblings by next-generation sequencing. The parents were heterozygous carriers. Before, the heterozygous form of this variant has been reported in a 15-year-old boy with short stature, advanced bone age, and dysmorphic features. Conclusions: SEMD-ACAN is a rare genetic condition that affects bone growth and development and can cause physical and developmental abnormalities. This article highlights the importance of considering genetic testing in characteristic symptoms associated with SEMD-ACAN, such as severe growth retardation and skeletal abnormalities.


  • Open Access

    SCOT Deficiency Mimicking Sepsis: An Unusual Cause of Increased Anion Gap Metabolic Acidosis

    by Pelin Teke Kısa, Semra Gürsoy, Pınar Seven, Neslihan Pirinc, Özlem Saraç Sandal, Gülhan Atakul, Filiz Hazan, Tijen Tanyalcın

    Introduction: Succinyl-CoA:3-oxoacid CoA transferase (SCOT, EC 2.8.3.5) deficiency is a rare autosomal recessive inborn error of metabolism (IEM). We report here an infant admitted to intensive care unit with the diagnosis of sepsis. Case Presentation: A five-month-old female patient was admitted to the intensive care unit with lethargy and respiratory distress. She had severe high anion gap metabolic acidosis. The IEM was screened by plasma amino acid analysis, showing no abnormalities, and by acylcarnitine analysis, showing low-normal levels of free carnitine. Urine organic acid analysis revealed massive ketonuria and elevated levels of dicarboxylic acids. Fatty acid oxidation disorder-targeted gene panel revealed a homozygous splice site variant (c.78+1_78+6 del) in the OXCT1 gene. Discussion and Conclusion: SCOT deficiency should be considered when massive ketosis is detected in increased anion gap metabolic acidosis with sepsis-like manifestation. Supportive therapy should be initiated quickly to prevent irreversible neurological damage.